Syndax Pharmaceuticals (SNDX) PT Raised to $56 at BTIG
Tweet Send to a Friend
(Updated - August 5, 2025 6:26 AM EDT)
BTIG analyst Justin Zelin raised the price target on Syndax Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BTIG analyst Justin Zelin raised the price target on Syndax Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


